Collaboration with Amgen to advance a cancer target discovered using DISCO’s proprietary surfaceome mapping technology Cologne, Germany, January ...

AUSTIN, Texas & LONDON--(BUSINESS WIRE)-- DISCO (NYSE: LAW), a creator of industry-leading litigation technology, has announced the expansion of its strategic eDiscovery and technology partnership ...

Disco Pharmaceuticals GmbH announced the final close of its seed round at €36 million (US$42 million), as it shapes up novel targets it has discovered with its surfaceome platform technology for ...